Brown Fat Activation Study

NCT02919176 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Obese
Metabolic Syndrome

Interventions

DRUG: Mirabegron
DRUG: Pioglitazone
DRUG: Mirabegron and Pioglitazone

Sponsor

Philip Kern

Collaborators

[object Object]